Antitumor Activity of Total Glycosides from Cimicifuga dahurica Against Hepatoma
Author Information
Author(s): Zheng Tian, Si Jianyong, Chang Qi, Zhou Liang, Chen Shilin, Xiao Peigen, Wu Erxi
Primary Institution: Children's Hospital Informatics Program at Harvard-MIT Division of Health Sciences and Technology, Children's Hospital Boston, Harvard Medical School
Hypothesis
The total triterpenoid glycosides from Cimicifuga dahurica may have antiproliferative activity and mechanisms that could be useful in the treatment of hepatoma.
Conclusion
Total glycosides from Cimicifuga dahurica may serve as a new therapy for hepatoma treatment.
Supporting Evidence
- TGA showed an IC50 of 21 μg/ml in HepG2 cells and 105 μg/ml in normal mouse hepatocytes.
- TGA induced G0/G1 cell cycle arrest at lower concentrations and G2/M arrest at higher concentrations.
- TGA inhibited the growth of implanted mouse H22 tumors in a dose-dependent manner.
Takeaway
This study found that a plant extract can help fight liver cancer by stopping cancer cells from growing and causing them to die.
Methodology
The study used MTT assays to evaluate cytotoxicity in HepG2 cells and normal mouse hepatocytes, along with in vivo tests in implanted mouse H22 hepatoma models.
Limitations
The study primarily focused on a specific type of cancer and may not be generalizable to other cancers.
Participant Demographics
Male CD-1 (ICR) mice were used for in vivo experiments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website